Moreover, the presence of SDB as well as a mean SpO2 < 94% were associated with an >2.2- (p = 0.016) and >2.5-fold (p = 0.014) increased risk for a higher MARK4 expression, respectively. This evidence concerns the gene MARK4 and sleep apnea syndrome.